Skip to main content
4 March 2021
Last updated:
Monday 1 March 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
    • Research Directory
    • Organisations
    • Interviewees
    • Terms
    • Topics
  • Contact Us

Research Directory

  • Delivery systems may be crucial to RNAi therapies

    Wednesday 3 March 2010
    Interviewee/Contributor
    Phil Haworth
    Organisation
    Silence Therapeutics Plc
    RNAi Ribonucleic Acid interence
    • Read more about Delivery systems may be crucial to RNAi therapies

Organisations

  • Kilburn & Strode LLP
  • BioCity Nottingham Ltd
  • Galapagos NV
  • Wellcome Trust
  • Novo Nordisk Foundation
  • Kiadis Pharma BV
  • Innovation and International Relationship
  • US Food and Drug Administration
  • University of Pennsylvania, Perelman School of Medicine
  • Progenitor Labs Ltd

Interviewees and Contributers

  • John Mayo
  • Rosie Bannister
  • Wes Kim
  • Martin Whitaker
  • Jan Fagerberg
  • Michel Goldman
  • Clare Ozawa
  • Christian Homsy et al
  • Kirsten Drejer
  • Ingmar Hoerr

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Microbiotica expands management team
Wednesday February 10 2021
Philippe Dro joins Scenic Biotech as independent chairman
Wednesday February 10 2021
NOXXON announces senior appointment to its new advisory board
Wednesday February 10 2021
Wendy Levin joins Biofidelity as chief medical officer
Wednesday February 10 2021
VarmX appoints Gerard Short as chief medical officer
Wednesday February 10 2021

© 2021 Evernow Publishing Ltd. Powered by Drupal.